TERAGENIX Trademark

Trademark Overview

On Thursday, February 14, 2002, a trademark application was filed for TERAGENIX with the United States Patent and Trademark Office. The USPTO has given the TERAGENIX trademark a serial number of 76373449. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Monday, June 25, 2007. This trademark is owned by Teragenix Corporation. The TERAGENIX trademark is filed in the Transportation & Storage Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

transport packaging and storage services for biological specimens under specific condition and in a manner that ensures the molecular stability of biological specimens

manufacturing services to the order and specification of others of the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries, namely, the manufacturing of quality control products such as panels and medical devices such as controls, standard and calibrators

Clinical trial management services and biological specimen collection services for the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries; Clinical trial management services including the design of clinical trials, the collection, handling, and storage of human biological specimens, the collection, discovery, analysis and presentation of clinical trial data for use in medical research, in-vitro diagnostic product development and pharmaceutical product development; Clinical trial management services including assistance with regulatory submissions, laboratory testing services and logistics management; Biological specimen collection services including the prospective collection of biological specimens, the design of collection protocols, the submission of regulatory filings, the transport of biological specimens, the collection of characterization data related to biological specimens and the accumulation of a database of characterization data related to biologi...
teragenix

General Information

Serial Number76373449
Word MarkTERAGENIX
Filing DateThursday, February 14, 2002
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateMonday, June 25, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 13, 2003

Trademark Statements

Goods and Servicestransport packaging and storage services for biological specimens under specific condition and in a manner that ensures the molecular stability of biological specimens
Goods and Servicesmanufacturing services to the order and specification of others of the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries, namely, the manufacturing of quality control products such as panels and medical devices such as controls, standard and calibrators
Goods and ServicesClinical trial management services and biological specimen collection services for the in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries; Clinical trial management services including the design of clinical trials, the collection, handling, and storage of human biological specimens, the collection, discovery, analysis and presentation of clinical trial data for use in medical research, in-vitro diagnostic product development and pharmaceutical product development; Clinical trial management services including assistance with regulatory submissions, laboratory testing services and logistics management; Biological specimen collection services including the prospective collection of biological specimens, the design of collection protocols, the submission of regulatory filings, the transport of biological specimens, the collection of characterization data related to biological specimens and the accumulation of a database of characterization data related to biological specimens

Classification Information

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code8 - Abandoned
Class Status DateMonday, June 25, 2007
Primary Code039
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code8 - Abandoned
Class Status DateMonday, June 25, 2007
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateMonday, June 25, 2007
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeragenix Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33309
Party NameTeragenix Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33309

Trademark Events

Event DateEvent Description
Monday, June 25, 2007ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Monday, June 25, 2007ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, April 3, 2007OPPOSITION SUSTAINED NO. 999999
Wednesday, September 24, 2003OPPOSITION INSTITUTED NO. 999999
Wednesday, July 2, 2003EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 13, 2003PUBLISHED FOR OPPOSITION
Wednesday, April 23, 2003NOTICE OF PUBLICATION
Thursday, March 20, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 14, 2003EXAMINERS AMENDMENT MAILED
Thursday, March 6, 2003PREVIOUS ALLOWANCE COUNT WITHDRAWN
Saturday, January 25, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 6, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 6, 2002PAPER RECEIVED
Friday, May 31, 2002NON-FINAL ACTION MAILED
Wednesday, May 8, 2002ASSIGNED TO EXAMINER

Related Keywords

teragenix biological services collection specimens clinical management trial including vitro data